These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9699667

  • 1. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T, Cao Y, Folkman J, Fine HA.
    Cancer Res; 1998 Aug 01; 58(15):3362-9. PubMed ID: 9699667
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J.
    Cancer Res; 2005 Sep 15; 65(18):8359-65. PubMed ID: 16166313
    [Abstract] [Full Text] [Related]

  • 3. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
    Ma HI, Lin SZ, Chiang YH, Li J, Chen SL, Tsao YP, Xiao X.
    Gene Ther; 2002 Jan 15; 9(1):2-11. PubMed ID: 11850717
    [Abstract] [Full Text] [Related]

  • 4. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM.
    Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618
    [Abstract] [Full Text] [Related]

  • 5. Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.
    Rodolfo M, Catò EM, Soldati S, Ceruti R, Asioli M, Scanziani E, Vezzoni P, Parmiani G, Sacco MG.
    Cancer Gene Ther; 2001 Jul 15; 8(7):491-6. PubMed ID: 11498770
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G, Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L.
    Gene Ther; 2002 Jul 15; 9(13):867-78. PubMed ID: 12080381
    [Abstract] [Full Text] [Related]

  • 7. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2003 Mar 15; 37(3):696-704. PubMed ID: 12601367
    [Abstract] [Full Text] [Related]

  • 8. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP.
    Mol Ther; 2001 Feb 15; 3(2):186-96. PubMed ID: 11237675
    [Abstract] [Full Text] [Related]

  • 9. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
    Matsuda KM, Madoiwa S, Hasumi Y, Kanazawa T, Saga Y, Kume A, Mano H, Ozawa K, Matsuda M.
    Cancer Gene Ther; 2000 Apr 15; 7(4):589-96. PubMed ID: 10811477
    [Abstract] [Full Text] [Related]

  • 10. Development of lentiviral vectors for antiangiogenic gene delivery.
    Shichinohe T, Bochner BH, Mizutani K, Nishida M, Hegerich-Gilliam S, Naldini L, Kasahara N.
    Cancer Gene Ther; 2001 Nov 15; 8(11):879-89. PubMed ID: 11773978
    [Abstract] [Full Text] [Related]

  • 11. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.
    Ma HI, Guo P, Li J, Lin SZ, Chiang YH, Xiao X, Cheng SY.
    Cancer Res; 2002 Feb 01; 62(3):756-63. PubMed ID: 11830530
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
    Gyorffy S, Palmer K, Gauldie J.
    Am J Pathol; 2001 Sep 01; 159(3):1137-47. PubMed ID: 11549607
    [Abstract] [Full Text] [Related]

  • 13. A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.
    Ciafrè SA, Barillari G, Bongiorno-Borbone L, Wannenes F, Izquierdo M, Farace MG.
    Gene Ther; 2002 Feb 01; 9(4):297-302. PubMed ID: 11896469
    [Abstract] [Full Text] [Related]

  • 14. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells.
    Indraccolo S, Morini M, Gola E, Carrozzino F, Habeler W, Minghelli S, Santi L, Chieco-Bianchi L, Cao Y, Albini A, Noonan DM.
    Cancer Res; 2001 Jul 15; 61(14):5441-6. PubMed ID: 11454689
    [Abstract] [Full Text] [Related]

  • 15. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X, Kanwar JR, Leung E, Lehnert K, Wang D, Krissansen GW.
    Cancer Gene Ther; 2001 Oct 15; 8(10):719-27. PubMed ID: 11687895
    [Abstract] [Full Text] [Related]

  • 16. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P.
    Lab Invest; 1997 Apr 15; 76(4):565-77. PubMed ID: 9111517
    [Abstract] [Full Text] [Related]

  • 17. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
    Igarashi T, Miyake K, Kato K, Watanabe A, Ishizaki M, Ohara K, Shimada T.
    Gene Ther; 2003 Feb 15; 10(3):219-26. PubMed ID: 12571629
    [Abstract] [Full Text] [Related]

  • 18. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen.
    Schmitz V, Wang L, Barajas M, Peng D, Prieto J, Qian C.
    Gene Ther; 2002 Dec 15; 9(23):1600-6. PubMed ID: 12424612
    [Abstract] [Full Text] [Related]

  • 19. Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
    Solly F, Fish R, Simard B, Bolle N, Kruithof E, Polack B, Pernod G.
    Cancer Gene Ther; 2008 Oct 15; 15(10):685-92. PubMed ID: 18535615
    [Abstract] [Full Text] [Related]

  • 20. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
    Hahn W, Ho SH, Jeong JG, Hahn EY, Kim S, Yu SS, Kim S, Kim JM.
    Gene Ther; 2004 May 15; 11(9):739-45. PubMed ID: 15103317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.